Takeda's pipeline has potential to contribute significantly to revenue growth over next decade

Osaka, japan--(business wire)--as part of its wave 1 pipeline market opportunity call, takeda pharmaceutical company limited (tse:4502/nyse:tak) (“takeda”) provided an update on its pipeline portfolio, which has the potential to contribute significantly to revenue growth for the company over the next decade. the company also shared its pts adjusted2 view for fy2019-fy2030 revenue cagr (low single-digit), as well as its goal for fy2019-fy2030 revenue cagr (mid-single-digit), amounting to jpy5 tr
TAK Ratings Summary
TAK Quant Ranking